Chronic Lymphocytic Leukaemia
Oncology·MeSH: Leukemia, B-Cell
Prevalence
30.0 / 100K
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Chronic Lymphocytic Leukaemia?
BioSniper tracks 2 drugs in development for Chronic Lymphocytic Leukaemia across 1 company.
How many clinical trials target Chronic Lymphocytic Leukaemia?
There are 3 clinical trials targeting Chronic Lymphocytic Leukaemia tracked by BioSniper.
What is the prevalence of Chronic Lymphocytic Leukaemia?
The estimated prevalence of Chronic Lymphocytic Leukaemia is approximately 30.0 per 100,000 population.
Deep-dive into Chronic Lymphocytic Leukaemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis